On January 31, 2026, BrainCo, a prominent company specializing in non-invasive brain-computer interface technology, announced the launch of a groundbreaking product specifically designed for children diagnosed with ADHD (Attention Deficit Hyperactivity Disorder). This innovative offering encompasses rehabilitation training software and a single-channel prefrontal EEG acquisition device, both of which have successfully secured medical device registration certificates.

Leveraging cutting-edge neurofeedback training technology, the product operates by gathering and scrutinizing prefrontal EEG signals via surface electrodes. Through this meticulous process, it aims to fine-tune EEG rhythms, thereby bolstering attention spans and self-control abilities in children with ADHD between the ages of 6 and 12. Looking ahead, NeuroXess (BrainCo) has outlined a strategic vision to undertake technological advancements centered around comprehensive full-lifecycle brain health management within the next 3 to 5 years.